Suppr超能文献

高危型宫颈病变患者阴道鳞状上皮内病变的危险因素。

Risk factors for vaginal squamous intra-epithelial lesions in women with high-grade cervical lesions.

机构信息

Lower Genital Tract Disease Center, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, Shanghai, China.

Puyang Oilfield General Hospital, Puyang, Henan, China.

出版信息

Int J Gynecol Cancer. 2024 Sep 2;34(9):1344-1348. doi: 10.1136/ijgc-2024-005531.

Abstract

OBJECTIVE

To investigate the high-risk factors associated with concurrent cervical intra-epithelial neoplasia (CIN) and vaginal intra-epithelial neoplasia (VaIN) in patients with high-grade lesions.

METHODS

This retrospective study at the Obstetrics and Gynecology Hospital of Fudan University included patients diagnosed with concurrent CIN2/3 and VaIN2/3 (concurrent group) over the period from January 1, 2019, to December 31, 2019. Patients with only CIN2/3 during the corresponding period were selected chronologically on a 1:2 basis (CIN group). Demographic data, human papillomavirus (HPV) infection rates, genotypes, and cytology results were compared between the groups.

RESULTS

A total of 128 patients were included. The median age in the concurrent group was 50 years (range 20-79), which was significantly higher than the median age of 38 (range 23-72) in the CIN group (p<0.001). The cytological sensitivity for identifying high-grade lesions was markedly higher in the concurrent group at 83.1% (103 out of 124) compared with 68.4% (175 out of 256) in the CIN-only group (p=0.002). The prevalence of HPV 16 was 62.8% in the concurrent group, significantly higher than 51.6% in the CIN group (p=0.04).

CONCLUSIONS

The risk of concurrent VaIN2/3 increases with age among women with CIN2/3. Cytology screening is effective for detecting concurrent VaIN2/3, with a sensitivity of 83.1%.

摘要

目的

探讨高级别病变患者中与宫颈上皮内瘤变(CIN)和阴道上皮内瘤变(VaIN)同时发生相关的高危因素。

方法

本研究回顾性分析了复旦大学妇产科医院 2019 年 1 月 1 日至 12 月 31 日期间诊断为 CIN2/3 和 VaIN2/3 同时存在的患者(同时组),并按照 1:2 的比例按照时间顺序选择同期仅存在 CIN2/3 的患者(CIN 组)。比较两组患者的人口统计学数据、人乳头瘤病毒(HPV)感染率、基因型和细胞学结果。

结果

共纳入 128 例患者。同时组的中位年龄为 50 岁(范围 20-79),明显高于 CIN 组的 38 岁(范围 23-72)(p<0.001)。同时组识别高级别病变的细胞学敏感性明显高于 CIN 组(83.1%,103/124),为 68.4%(175/256)(p=0.002)。同时组 HPV16 的患病率为 62.8%,明显高于 CIN 组的 51.6%(p=0.04)。

结论

在 CIN2/3 的女性中,VaIN2/3 同时发生的风险随年龄增加而增加。细胞学筛查对于检测同时存在的 VaIN2/3 是有效的,敏感性为 83.1%。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验